Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Maus, Marcela
Item TypeName
Concept Immunotherapy, Adoptive
Concept Immunotherapy
Academic Article CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies.
Academic Article Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
Academic Article TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Academic Article T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.
Academic Article Engineered T cells for cancer therapy.
Academic Article Antibody-modified T cells: CARs take the front seat for hematologic malignancies.
Academic Article Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.
Academic Article Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
Academic Article Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity.
Academic Article Immunotherapy with chimeric antigen receptors for multiple myeloma.
Academic Article Adoptive immunotherapy for cancer or viruses.
Academic Article HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells.
Academic Article Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.
Academic Article Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
Academic Article 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Academic Article Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.
Academic Article Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy.
Academic Article Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.
Academic Article Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.
Academic Article Chimeric antigen receptor T cell therapy: 25years in the making.
Academic Article The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma.
Academic Article Chimeric antigen receptor-modified T cells strike back.
Academic Article CAR-T Cell Therapies From the Transfusion Medicine Perspective.
Academic Article Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies.
Academic Article The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.
Academic Article CARs in the Lead Against Multiple Myeloma.
Academic Article Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells.
Academic Article Immunotherapy for Brain Tumors.
Academic Article Ibrutinib treatment improves T cell number and function in CLL patients.
Academic Article A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
Academic Article Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
Academic Article Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.
Academic Article Toxicities associated with immunotherapies for hematologic malignancies.
Academic Article Tumour tamed by transfer of one T cell.
Academic Article Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.
Academic Article Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.
Academic Article Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
Academic Article Making CAR T Cells a Solid Option for Solid Tumors.
Academic Article Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.
Academic Article Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies.
Academic Article ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Academic Article CAR-T cells beyond CD19, UnCAR-Ted territory.
Academic Article Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.
Academic Article Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer.
Academic Article Biomanufacturing for clinically advanced cell therapies.
Academic Article Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.
Academic Article Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response.
Academic Article Gene editing for immune cell therapies.
Academic Article Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Grant Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
Academic Article Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.
Academic Article CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
Academic Article Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Academic Article Emerging Immunotherapies for Malignant Glioma: From Immunogenomics to Cell Therapy.
Search Criteria
  • Immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.